zeta-Crystallin is a bcl-2 mRNA binding protein involved in bcl-2 overexpression in T-cell acute lymphocytic leukemia

The human antiapoptotic Bcl-2 gene has been discovered in t(14;18) B-cell leukemias/lymphomas because of its overexpression caused at a transcriptional control level by the Bcl-2/IgH fusion gene. We were the first to disclose the post-transcriptional control of Bcl-2 expression mediated by interactions of an adenine + uracil (AU)-rich element (ARE) in the 3'-UTR of Bcl-2 mRNA with AU-binding proteins (AUBPs). Here, we identify and characterize zeta-crystallin as a new Bcl-2 AUBP, whose silencing or overexpression has impact on Bcl-2 mRNA stability. An increased Bcl-2 level observed in normal phytohemagglutinin (PHA)-activated T lymphocytes, acute lymphatic leukemia (ALL) T-cell lines, and T cells of patients with leukemia in comparison with normal non-PHA-activated T lymphocytes was concomitant with an increase in zeta-crystallin level. The specific association of zeta-crystallin with the Bcl-2 ARE was significantly enhanced in T cells of patients with ALL, which accounts for the higher stability of Bcl-2 mRNA and suggests a possible contribution of zeta-crystallin to Bcl-2 overexpression occurring in this leukemia.